These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 22187146)
1. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies. Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146 [TBL] [Abstract][Full Text] [Related]
2. Design, recombinant expression and convenient A-chain N-terminal europium-labelling of a fully active human relaxin-3 analogue. Zhang WJ; Luo X; Song G; Wang XY; Shao XX; Guo ZY FEBS J; 2012 Apr; 279(8):1505-12. PubMed ID: 22375707 [TBL] [Abstract][Full Text] [Related]
3. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays. Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726 [TBL] [Abstract][Full Text] [Related]
4. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
5. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone. Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984 [TBL] [Abstract][Full Text] [Related]
6. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation. Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870 [TBL] [Abstract][Full Text] [Related]
7. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays. Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442 [TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions. Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069 [TBL] [Abstract][Full Text] [Related]
9. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay. Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458 [TBL] [Abstract][Full Text] [Related]
10. Development of a selective agonist for relaxin family peptide receptor 3. Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363 [TBL] [Abstract][Full Text] [Related]
11. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions. Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977 [TBL] [Abstract][Full Text] [Related]
12. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation. Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012 [TBL] [Abstract][Full Text] [Related]
13. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155 [TBL] [Abstract][Full Text] [Related]
14. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies. Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372 [TBL] [Abstract][Full Text] [Related]
15. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways. Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890 [TBL] [Abstract][Full Text] [Related]
16. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2. Scott DJ; Rosengren KJ; Bathgate RA Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049 [TBL] [Abstract][Full Text] [Related]
17. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands. Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795 [TBL] [Abstract][Full Text] [Related]
18. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin. Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406 [TBL] [Abstract][Full Text] [Related]
19. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4. Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393 [TBL] [Abstract][Full Text] [Related]
20. Relaxin family peptides and their receptors. Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]